Amicus Therapeutics Is Revolutionizing Treatment For Rare Diseases

Amicus Therapeutics is a rare company specializing in rare debilitating disorders. They are leading the healthcare industry forward with their biotechnology company that is currently global. They are listed under the Nasdaq as FOLD. They have spent years working to find cures and medications for the worlds most devastating rare and orphan diseases. Their most recognized product is migalastat, which is a individually designed medication for individuals suffering from Fabry disease. They have also brought to market SD-101, which is the first medication on the market which helps treat Epidermolysis Bullosa; a rare genetic connective tissue disorder. They are working on therapies for a range of diseases including Fabry disease, Pompe disease, and various other Lysosomal Storage Disorders.

The programs they invest in have to deal with rare diseases or devastating disorders, the therapy being created and promoted must be the best option on the market, and it needs to be supported by promising, detailed and customer-minded clinical data. Amicus Therapeutics is renowned for maintaining a personal and sympathetic relationship with their patients, caregivers, and families. They nurture their relationship with their patients by hanging photographs of them with the diseases they suffer from and sharing a narrative on the struggles they endure everyday. Their lives are honored and their identities are recognized. The Amicus Therapeutics team consistently look forward towards the future developing new technologies to better the lives of their patients.

They believe in and understand the fight against rare diseases. They work to support the communities around their patients while constantly innovating the therapies they offer. Amicus believes in taking intelligent and well thought out risks, as well as never letting themselves be held down by prior ways of thinking.

Amicus employees also pride themselves on constantly remaining open, honest, and respectful. They are recognized for thinking differently, having fun with their research and keeping a balanced work and personal life.

Patient Advocacy is extremely important to Amicus Therapeutics, so much so they have an entire group dedicated to it. A larger variety of people involved with the professionals, patients and their families participate in their Patient Advocacy group. This interaction shows that there is a great opportunity where patients, scientists, professionals and employees can work together to create a better environment, experience and therapies for the present and the future.